http://www.massdevice.com/invivo-therapeutics-touts-case-study-1st-spine-scaffold-implant/
InVivo TherapeuticsInVivo Therapeutics (NSDQ:NVIV) this week touted a case study of the 1st implantation of its spinal scaffold, a bioresorbable device designed to help treat traumatic spinal cord injuries. The study, published in Neurosurgery, the journal of the Congress of Neurological Surgeon…